XML 25 R15.htm IDEA: XBRL DOCUMENT v3.25.1
BUSINESS SEGMENT
3 Months Ended
Mar. 31, 2025
BUSINESS SEGMENT  
BUSINESS SEGMENT

9.    BUSINESS SEGMENT

The Company operates in a single reportable segment, referred to as safety medical syringes and other safety medical devices. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources

and evaluating financial performance.  The accounting policies of our single reportable segment are the same as those for the Company as a whole.

The following are summaries of the Company’s sales and long-lived assets by geography:

Three Months Ended

Three Months Ended

    

March 31, 2025

    

March 31, 2024

    

U.S. sales

$

7,432,309

$

6,641,168

North and South America sales (excluding U.S.)

 

553,500

 

154,633

Other international sales

 

309,364

 

803,562

Total sales

$

8,295,173

$

7,599,363

Long-lived assets by geography are as follows:

    

March 31, 2025

    

December 31, 2024

Long-lived assets

U.S.

$

81,657,137

$

83,373,876

International

3,895,488

3,974,642

Total

$

85,552,625

$

87,348,518